Ascendis Pharma A/S Adjustments For Increase Decrease In Deferred Income
Ascendis Pharma A/S (ASND) reported Adjustments For Increase Decrease In Deferred Income of -EUR 327.00 thousand for the 9-month period ending 2021-09-30, per its 6-K filed 2021-11-10.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncome · last filed 2021-11-10
- Ascendis Pharma A/S adjustments for increase decrease in deferred income for the quarter ending 2021-09-30 was -109.00K EUR, a 148.88% decline year-over-year.
- Ascendis Pharma A/S adjustments for increase decrease in deferred income for the quarter ending 2021-06-30 was -109.00K EUR.
- Ascendis Pharma A/S adjustments for increase decrease in deferred income for the quarter ending 2021-03-31 was -109.00K EUR.
- Ascendis Pharma A/S adjustments for increase decrease in deferred income for the quarter ending 2020-12-31 was 140.00K EUR.
| Period end | Adjustments For Increase Decrease In Deferred Income 3 month | Adjustments For Increase Decrease In Deferred Income 6 month | Adjustments For Increase Decrease In Deferred Income 9 month | Adjustments For Increase Decrease In Deferred Income 12 month |
|---|---|---|---|---|
| 2021-09-30 | -109.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2021-11-10 | -218.00K EUR derived: sum of 2 quarters · filed 2021-11-10 | -327.00K EUR 6-K · filed 2021-11-10 | -187.00K EUR derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | -109.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2021-08-27 | -218.00K EUR 6-K · filed 2021-08-27 | -78.00K EUR derived: sum of 3 quarters · filed 2021-08-27 | 145.00K EUR derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | -109.00K EUR 6-K · filed 2021-05-27 | 31.00K EUR derived: sum of 2 quarters · filed 2021-05-27 | 254.00K EUR derived: sum of 3 quarters · filed 2021-11-10 | -89.00K EUR derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | 140.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | 363.00K EUR derived: sum of 2 quarters · filed 2021-11-10 | 20.00K EUR derived: sum of 3 quarters · filed 2021-11-10 | -495.00K EUR 20-F · filed 2021-03-10 |
| 2020-09-30 | 223.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2021-11-10 | -120.00K EUR derived: sum of 2 quarters · filed 2021-11-10 | -635.00K EUR 6-K · filed 2021-11-10 | -1.15M EUR derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -343.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2021-08-27 | -858.00K EUR 6-K · filed 2021-08-27 | -1.37M EUR derived: sum of 3 quarters · filed 2021-08-27 | -2.16M EUR derived: sum of 4 quarters · filed 2021-08-27 |
| 2020-03-31 | -515.00K EUR 6-K · filed 2021-05-27 | -1.03M EUR derived: sum of 2 quarters · filed 2021-05-27 | -1.81M EUR derived: sum of 3 quarters · filed 2021-05-27 | -2.73M EUR derived: sum of 4 quarters · filed 2021-05-27 |
| 2019-12-31 | -515.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | -1.30M EUR derived: sum of 2 quarters · filed 2021-03-10 | -2.21M EUR derived: sum of 3 quarters · filed 2021-03-10 | -6.04M EUR 20-F · filed 2021-03-10 |
| 2019-09-30 | -783.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2020-11-12 | -1.70M EUR derived: sum of 2 quarters · filed 2020-11-12 | -5.53M EUR 6-K · filed 2020-11-12 | |
| 2019-06-30 | -917.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2020-08-27 | -4.75M EUR 6-K · filed 2020-08-27 | ||
| 2019-03-31 | -3.83M EUR 6-K · filed 2020-05-19 | |||
| 2018-12-31 | 0.00 EUR 20-F · filed 2019-04-03 | |||
| 2018-03-31 | 0.00 EUR 6-K · filed 2018-05-30 | |||
| 2017-12-31 | -94.00K EUR 20-F · filed 2020-04-03 | |||
| 2017-03-31 | 0.00 EUR 6-K · filed 2018-05-30 | |||
| 2016-12-31 | -2.98M EUR 20-F · filed 2019-04-03 | |||
| 2015-12-31 | -4.83M EUR 20-F · filed 2018-03-28 |